Programme
Programme at a glance
10.00
10.30
Coffee break & Poster Viewing
12.00
13.00
Special Symposium – Takeda (12:15 – 12:30)
Recombinant ADAMTS13: A Breakthrough Innovation in the Treatment of cTTP
Čermáková Zuzana
(not part of the main CME/CPD programme)
Lunch break
13.00
13.45
13.45
14.00
Short break & Poster viewing
14.00
15.00
Special Symposium – Octapharma
VWD in Focus: Bridging Gaps in Diagnosis and Long-Term Management
(not part of the main CME/CPD programme)
15.00
15.30
Coffee Break
15.30
16.15
17.15
17.45
Opening Ceremony
17.45
19.00
Welcome Reception
08.30
09.00
09.00
10.30
10.30
11.00
Coffee break and poster viewing
11.00
11.30
State of the Art
Immune tolerance induction (ITI) in haemophilia A inhibitor patients: MOTIVATE first per protocol interim analysis
Carmen Escuriola, Director of the Haemophilia Centre Rhein Main – HZRM, Frankfurt
State of the Art
Clonal haematopoiesis and modulation of atherothrombotic
risk cardiovascular death
Christoph Binder, Medical University of Vienna
11.30
12.00
State of the Art
Haemophilia: From Diagnosis to Next-Generation Care and Treatment
Cedric Hermans, Saint-Luc University Hospital, Brussels, Belgium
State of the Art
Von Willebrand disease and von Willebrand factor: an old story, a new perspective
Eugenia Biguzzi, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
12.00
13.30
Special Symposium – SOBI (12.15 – 13.15)
(not part of the main CME/CPD programme)
Lunch break & poster viewing
13.30
14.15
Plenary lecture
Understanding the role of hemostasis in acute ischemic stroke treatment failure
Zsuzsa Bagoly, Department of Laboratory Medicine, University of Debrecen, Hungary
14.15
14.30
Short break
14.30
15.30
15.30
16.00
Coffee break & Poster viewing
16.00
17.15
17.15
18.30
Poster Reception
19.00
23.30
Congress Party
09.00
10.00
10.00
10.30
Coffee break & Poster viewing
10.30
11.00
State of the Art
Clinical applications of platelet proteomics
Laura Gutiérrez, Universidad de Oviedo, Spain
State of the Art
Thrombosis and Obstetric Health – can we do any better?
Catherine Bagot, University of Glasgow
11:00
11:30
State of the Art
Current management of haemophilia in children
Jan Blatný, University Hospital Brno, Czech Republic
State of the Art
Cancer and thrombosis: improvements in prediction, prevention, and treatment
Nick van Es, Vascular Medicine, Amsterdam University Medical Center
12.30
13.30
Lunch break & Poster viewing
14.15
14.30
Closing ECTH 2025